More Clinical Articles


Engineering a Culture of Innovation Part 1: Creating a Win/Win Attitude

Dr Nicola Davies, (Feb 23, 2015)

“For the natural born innovator, risk and failure are akin to an old, comfortable pair of shoes” - Henry Doss, ecosystem architect and co-author of ‘The Rainforest Scorecard: A Practical Framework for Growing Innovation Potential.’ We investigate how a culture of innovation can be created.

Fast and Frugal Experiments are the Way Forward

Dr Nicola Davies, (Feb 19, 2015)

We speak to co-author of The Innovator’s Method, Nathan Furr, about how pharma can enhance innovation, decrease costs, and accelerate drug discovery time frames with fast and frugal experiments in the face of uncertainty.

Clinical Trials - Pharma in the Twittersphere

Dr Nicola Davies, (Feb 13, 2015)

The merging of the modern advent of the public Twittersphere with the traditional methodology of clinical trials has provided a patient-centric, patient-driven, and patient-funded opportunity within disease treatment research.

Greater Transparency & Collaboration Critical to Drug Discovery

Zuzanna Fimińska, (Feb 11, 2015)

Scientific and organizational challenges are crippling pharma’s drug discovery efforts. Introducing new drugs depends on the industry’s ability to pool resources, cooperate, and embrace transparency.

Leveraging Big Data to simplify clinical trials and fix R&D

Zuzanna Fimińska, (Feb 6, 2015)

Pharma needs to embrace Big Data and technology solutions that facilitate trials to cure R&D stagnation.

Getting value from oral oncolytics

Adam Hill, (Feb 2, 2015)

Oral cancer drugs can offer a more convenient alternative to traditional IV therapies when it comes to treating patients, but issues such as adherence and reimbursement still need to be ironed out, while payers have to be convinced that oral agents represent value for money.

Translating Patient Centricity into Organizational Reality

Adam Hill, (Jan 22, 2015)

Positive patient experiences and patient outcomes with high recruitment, adherence and retention result from alignment of the HEART, HEAD and HANDS within the research sponsor’s organization and among all key stakeholders.

Open Data Sharing: Turf Wars v Innovation

Deirdre Coleman, (Jan 13, 2015)

There is consensus around the idea that greater access to patient-level clinical data is a good thing – good for science, business and humanity. However, sharing data brings with it a host of benefits, questions and risks for the industry.

Rebuilding Pharma Begins with Patients

Hugo Stephenson, (Jan 8, 2015)

Successfully engaging patients in a clinical trial setting is a challenge. Hugo Stephenson MD, Executive Chairman, DrugDev looks at the key principles of patient engagement that work.

Year in Review 2014: R&D

Zuzanna Fimińska, (Jan 2, 2015)

2014 buzzed with discussion on how to make clinical trials more patient centric. We tried to identify key obstacles to patient enrollment and suggested practical solutions on how to overcome them. We also looked at technologies that will revolutionize R&D and celebrated medical breakthroughs.